Outcome of board meeting dated 14th August 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The board of Triochem Products approved the unaudited standalone financial results for the quarter ended 30th June 2025. Total income from operations stood at ₹22.10 lakhs, down from ₹22.97 lakhs in the same quarter last year and ₹32.47 lakhs in the preceding March quarter. The company posted a net loss after tax of ₹3.06 lakhs, narrower than the ₹7.84 lakh loss in Q1 FY25 but wider than the operating loss before tax of ₹15.24 lakhs versus ₹9.62 lakhs a year ago. Management disclosed that the company has temporarily reduced business activity due to the lingering impact of the Covid-19 pandemic on its relationship-driven business, with no significant improvement expected in the near term. The statutory auditor issued an unqualified review report, and the company stated it has sufficient liquidity and is making regular payments to suppliers and employees.
Continued operating losses and a deliberate scale-down of operations raise concerns about the company's earning capacity, though the narrowing of bottom-line loss and comfortable liquidity cushion provide some reassurance for shareholders in the near term.